Research Study Findings from Research Center for Hematology Update Understanding of Chronic Myelogenous Leukemia (The case of successful therapy with Nilotinib in patients with Ph-positive chronic myelogenous leukemia of chronic phase resistant...).

MLA

“Research Study Findings from Research Center for Hematology Update Understanding of Chronic Myelogenous Leukemia (The Case of Successful Therapy with Nilotinib in Patients with Ph-Positive Chronic Myelogenous Leukemia of Chronic Phase Resistant...).” Hematology Week, Apr. 2023, p. 864. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=163081981&authtype=sso&custid=ns315887.

APA

Research Study Findings from Research Center for Hematology Update Understanding of Chronic Myelogenous Leukemia (The case of successful therapy with Nilotinib in patients with Ph-positive chronic myelogenous leukemia of chronic phase resistant...). (2023). Hematology Week, 864.

Chicago

“Research Study Findings from Research Center for Hematology Update Understanding of Chronic Myelogenous Leukemia (The Case of Successful Therapy with Nilotinib in Patients with Ph-Positive Chronic Myelogenous Leukemia of Chronic Phase Resistant...).” 2023. Hematology Week, April, 864. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=163081981&authtype=sso&custid=ns315887.